Significant increase in plasma 4β-hydroxycholesterol concentration in patients after kidney transplantation.
about
CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease.Perspective: 4β-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A.The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation.An Exposure-Response Modeling Approach to Examine the Relationship Between Potency of CYP3A Inducer and Plasma 4β-Hydroxycholesterol in Healthy Subjects.Pretransplant 4β-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation.Use of 4β-hydroxycholesterol in animal and human plasma samples as a biomarker for CYP3A induction.
P2860
Significant increase in plasma 4β-hydroxycholesterol concentration in patients after kidney transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Significant increase in plasma ...... after kidney transplantation.
@en
Significant increase in plasma ...... after kidney transplantation.
@nl
type
label
Significant increase in plasma ...... after kidney transplantation.
@en
Significant increase in plasma ...... after kidney transplantation.
@nl
prefLabel
Significant increase in plasma ...... after kidney transplantation.
@en
Significant increase in plasma ...... after kidney transplantation.
@nl
P2093
P2860
P356
P1476
Significant increase in plasma ...... after kidney transplantation.
@en
P2093
Fuminori Sato
Hiroki Itoh
Hiromitsu Mimata
Kanako Kawasaki
Keiko Ohno
Satoshi Kishino
Takashi Fujioka
Yosuke Suzuki
Yuhki Sato
Yukie Sato
P2860
P304
P356
10.1194/JLR.P040022
P577
2013-07-04T00:00:00Z